6 completed, 2 unknown, 1 active not recruiting, 1 recruiting. 11 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 11 | Completed 6, Unknown 2, Active not recruiting 1, Recruiting 1, Terminated 1 |
Follow Sexuality: new trials by email Literature Review of Sexuality trials Research Report on Sexuality
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Androgen Effects on the Reproductive Neuroendocrine Axis, 2025 Version Testosterone Cypionate 50 milligrams per millileter (mg/mL) Injectable Solution - Transgenderism, Reproductive Issues | Phase 4 | Recruiting | University of California, San Diego | 80 | 2025-12-05 | 2026-01-15 |
| Superiority of On-demand PrEP Versus PEP on Using Doxycycline for Preventing STI in MSM DoxyODPrEP, DoxyPEP - Sexually Transmitted Diseases, Bacterial, Syphilis | Phase 4 | Active not recruiting | Chinese University of Hong Kong | 300 | 2025-03-29 | 2026-06-05 |
| Androgen Effects on the Reproductive Neuroendocrine Axis Testosterone Cypionate 50 MG/ML Injectable Solution - Transgenderism, Reproductive Issues | Phase 4 | Terminated | University of California, San Diego | 2 | 2025-02-26 | 2025-07-22 |
| Drug-Drug Interaction Study in Trans Women Living With HIV Biktarvy 50/200/25 Tab, Estradiol Tablets - Hiv, Transgenderism | Phase 4 | Unknown | Maple Leaf Research | 45 | 2022-11-23 | 2024-09-26 |
| Evaluation of Doxycycline Post-exposure Prophylaxis to Reduce Sexually Transmitted Infections in PrEP Users and HIV-infected Men Who Have Sex With Men Doxycycline Hyclate Delayed-Release 200 mg - Gonorrhea, Chlamydia | Phase 4 | Completed | University of California, San Francisco | 641 | 2019-11-26 | 2024-07-12 |
| Oral Doxycycline for the Prevention of Syphilis in Men Who Have Sex with Men (DaDHS) Doxycycline, Placebo - Syphilis, Sexually Transmitted Infections | Phase 4 | Completed | British Columbia Centre for Disease Control | 52 | 2019-08-15 | 2025-02-12 |
| Tenofovir/Emtricitabine With Doxycycline for Combination HIV and Syphilis Pre-exposure Prophylaxis in HIV-negative MSM Doxycycline 100mg PO daily x 12 months, Tenofovir/emtricitabine 200/300mg PO daily, Doxycycline 100mg PO daily x 6 months - HIV, Syphilis | Phase 4 | Completed | British Columbia Centre for Disease Control | 52 | 2018-05-15 | 2024-08-02 |
| PrEPared and Strong: Clinic-Based PrEP for Black MSM Enhanced PrEP Adherence, Standard PrEP Adherence - HIV/AIDS | Phase 4 | Completed | Columbia University | 204 | 2015-03-30 | 2018-05-17 |
| Breast Cancer, Sexuality and Black Cohosh WHOQOL questionnaire, FSFI questionnaire, kupperman scale - Sexuality | Phase 4 | Unknown | Irmandade da Santa Casa de Misericordia de Sao Paulo | 60 | 2014-01-01 | 2017-03-20 |
| Sex Steroids and the Serotonin Transporter Testolactone undecanoate, Lynestrenol, Cyproterone Acetate - Transsexualism | Phase 4 | Completed | Medical University of Vienna | 32 | 2010-02-01 | 2014-01-03 |
| Effects of Tribulus Terrestris on Sexual Function in Post-menopausal Women Placebo, Tribulus terrestris - Sexual Functions and Problems in the Adult | Phase 4 | Completed | Faculdade de Ciências Médicas da Santa Casa de São Paulo | 60 | 2009-01-01 | 2015-11-10 |
Homosexuality (5) · Sexually Transmitted Diseases (4) · Syphilis (4) · Transsexualism (4) · Acquired Immunodeficiency Syndrome (3) · Chlamydia Infections (2) · Gonorrhea (2) · Gender Dysphoria (1) · Sexual Dysfunction, Physiological (1) · Sexually Transmitted Diseases, Bacterial (1)
Behavior (11) · Sexual Behavior (11) · Genital Diseases (7) · Urogenital Diseases (7) · Communicable Diseases (6) · Infections (6) · Bacterial Infections (4) · Bacterial Infections and Mycoses (4) · Disease Attributes (4) · Gram-Negative Bacterial Infections (4) · Pathologic Processes (4) · Pathological Conditions, Signs and Symptoms (4) · Spirochaetales Infections (4) · Treponemal Infections (4)
Doxycycline (2) · Estradiol (2) · 5-alpha Reductase Inhibitors (1) · Aromatase Inhibitors (1) · Cyproterone Acetate (1) · Emtricitabine (1) · Lynestrenol (1) · Surveys and Questionnaires (1) · Tamoxifen (1) · Tenofovir (1) · Tribulus extract (1) · black cohosh root extract (1) · exemestane (1) · testosterone 17 beta-cypionate (1) · testosterone undecanoate (1)
British Columbia Centre for Disease Control (2) · University of California, San Diego (2) · Chinese University of Hong Kong (1) · Columbia University (1) · Faculdade de Ciências Médicas da Santa Casa de São Paulo (1) · Irmandade da Santa Casa de Misericordia de Sao Paulo (1) · Maple Leaf Research (1) · Medical University of Vienna (1) · University of California, San Francisco (1)
United States (4) · Canada (3) · Brazil (2) · Austria (1) · Hong Kong (1)
Antoni Duleba, MD (2) · Troy Grennan, MD (2) · Anne Luetkemeyer, MD (1) · Mona Loutfy, MD, MPH (1) · Paul W Colson, PhD (1) · Rupert Lanzenberger, MD A/Prof (1) · Tsz Ho Kwan, PhD (1)
PMID 25497691, PMID 25585069, PMID 25870333, PMID 32385678, PMID 37018493, PMID 38656217, PMID 39363100, PMID 40147465, PMID 40637301
R01HD111650 (2), R01AI143439 (1), R01MH098723 (1)